Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking?
... nurses and other HCPs, and 250 people living with relapsing MS. Interviews focused on understanding and ... MS nurses and other HCPs (n=250) and people with relapsing MS (n=250). Following their survey, physicians ... and problems with strength and coordination. The relapsing forms of MS are the most common. About the ...Prozac Reduces Disease Activity in MS Patients
... study finds antidepressant cut inflammation in relapsing remitting illness WEDNESDAY, April 30 ... help reduce disease activity in people with the relapsing remitting form of multiple sclerosis (MS), a new ... about the use of fluoxetine in patients with relapsing remitting MS can be made, the study authors ....Studies attribute recent increase in multiple myeloma survival to novel therapies
... improvement in overall survival for patients relapsing after 2000, compared with those relapsing before 2000 (24 vs. 12 months). Patients relapsing before 2000 were less likely to receive a prompt ...Diabetes drug shows promise against multiple sclerosis
... in diabetes shows some protective effects in the brains of patients with relapsing remitting multiple sclerosis, researchers at the University of Illinois at ... . In a small, double-blinded clinical trial, patients with relapsing remitting multiple sclerosis were assigned to take pioglitazone (a drug ...NEWSWEEK Cover: The Hunt for an Addiction Vaccine
... for Addiction are Treating the Disease as Chronic, relapsing Brain Disorder Advances Made in Understanding Biology of Addiction 'and ... reports that this emerging paradigm treats addiction as a chronic, relapsing brain disorder to be managed with all the tools at medicine's disposal. ...Researchers identify potential patient safety risks among methadone maintenance treatment patients
... The BMC study appears in the July issue of Journal of General Internal Medicine . MMT is a chronic therapy for opioid dependence, a chronic relapsing disease that often requires lifelong treatment. MMT typically is provided separately from medical care. Ideally, when patients in MMT engage in ...New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report
... Vaccine II-39 Liver Transplantation II-39 Treatment Costs II-40 Types of Treatment Responses II-40 Sustained Response II-40 relapsing (Transient) Response II-40 Breakthrough Response II-40 Null Response II-40 Monitoring Tests II-41 Laboratory tests II-41 Medical ...Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting
... Phase I/II Study of Rituxan in Combination with DOXIL in Patients with relapsing or Refractory B-Cell Lymphoma: Clinical Efficacy without Cardiac ... Provide Therapeutic Advantage for High-Risk Multiple Myeloma Patients relapsing within 12 Months of Stem Cell Transplant - Shaji Kumar, Mayo Clinic, ...Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
... noted a significant improvement in overall survival for patients relapsing after 2000, compared with those relapsing before 2000 (24 vs. 12 months). Patients relapsing before 2000 were less likely to receive a prompt transplant and more ...Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases
... 15 to 44 years, depression is the most disabling medical illness in the United States. The prevalence of major depression, known to be a chronic and relapsing illness, is approximately 17 percent, affecting almost 1 in 5 persons. Medications and psychiatric therapy can effectively treat many patients ...ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple Sclerosis
... of Neurology, Cologne City Hospitals, Germany. As previously reported, ATL/TV1102 significantly reduced disease activity in patients with relapsing Remitting Multiple Sclerosis (RRMS) in a randomized, double-blind, placebo-controlled Phase II study designed to obtain evidence of ATL/TV1102's ...Gastroesophageal reflux disease
... Disease ) Regional Enteritis (Crohn's Disease ) Reiter's Syndrome relapsing Urinary Tract Infection (Recurring Urinary Tract Infection ) relapsing UTI (Recurring Urinary Tract Infection ) ... The drug discussed ...Cocaine: How addiction develops
... reactivated. In contrast, NR1 deficient animals proved to be resistant to relapsing into the addiction. "It is fascinating to observe how individual ... for treating addiction. Thus, blocking the NR1 receptor might protect from relapsing into addiction. Selective activation of GluR1 would even contribute to ...MS study offers theory for why repair of brain's wiring fails
... immature oligodendrocytes to the myelin sheath to repair the damage, for a time. This explains why, in the most common form of the disease, known as relapsing remitting MS, the symptoms -- which range from tingling and numbness in the limbs to loss of vision and paralysis -- disappear or are greatly ...New genetic markers for ulcerative colitis identified, researchers report in Nature Genetics
... pathways involved in the disease and may lead to the development of new treatments that specifically target them. Ulcerative colitis is a chronic, relapsing disorder that causes inflammation and ulceration in the inner lining of the rectum and large intestine. The most common symptoms are diarrhea ...Positive results in Phase 2 trial of treatment of C-difficile-associated diarrhea
... "We are delighted with these dramatic results. CDAD is a growing and serious epidemic, with twenty to fifty percent of hospitalized patients relapsing after receiving antibiotic treatment," said Donna Ambrosino, MD, Executive Director of the MBL and Professor of Pediatrics at UMMS. "The ...Brain-nourishing molecule may predict schizophrenia relapse
... the drug is becoming less effective and a relapse is imminent, the researchers say. Decreased BDNF levels already have been associated with relapsing bipolar disease and depression, Dr. Buckley says. Dr. Pillai and others have shown that the BDNF levels in patients with schizophrenia are generally ...Mummy lice found in Peru may give new clues about human migration
... people who dont have the opportunity to change their clothes are the ones at risk for epidemic typhus, which along with the lesser-known diseases of relapsing fever and trench fever are carried by body lice, Reed said. These pests lay their eggs in clothing fibers and washing the clothes is all it takes to ...Staphylococcus aureus hides out in cells
... an intracellular pathogen, but the molecular details that govern its extended persistence remain largely unknown. The bacteria can generate relapsing infections even years after the first episode was apparently cured. “S. aureus intracellular survival appears related to its capability to adopt ...Susceptibility to Crohn's disease -- an important new clue
... Crohn’s disease is a chronic relapsing inflammatory disorder of the intestinal tract that affects an estimated 0.15% of people in the developed world. Common symptoms include abdominal ...Novel mechanism of action of new drug for MS identified
... a drug developed by Novartis, has shown considerable therapeutic effects in a recent small, placebo-controlled clinical trial involving patients with relapsing multiple sclerosis. The study was published in the September 2006 issue of the New England Journal of Medicine by an international research team. ...Altered perception of reward in human cocaine addiction
... "The dysfunctional interplay between reward processing and control of behavior observed in these studies could help to explain the chronically relapsing nature of drug addiction," Goldstein said. "Our results also suggest the need for new clinical interventions aimed at helping drug abusers manage ...Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis
... Phase II Study of Ofatumumab to Treat relapsing Remitting Multiple Sclerosis COPENHAGEN, ... (HuMax-CD20(R)) for the treatment of relapsing remitting multiple sclerosis (RRMS). ... lesions from week 8 to week 24. About relapsing Remitting Multiple Sclerosis Multiple Sclerosis ...Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
... Prior to that, Lorianne held senior leadership positions at Chiron and Berlex, where she was instrumental in development of Betaseron(R) for relapsing forms of multiple sclerosis as well as numerous oncology programs. Dr. Masuoka received her M.D. from the University of California, Davis , ...AEterna Zentaris Presents Data Supporting Evaluation of AEZS-108 in Prostate Cancer at ASCO Meeting
... Conclusion - In virtually all patients with prostate cancer, tumor cells appear to express LHRH receptors; - Even tumors persisting or relapsing after castration or prolonged hormonal treatment with LHRH agonists retain the expression of LHRH receptors; - The continued ...BioMS Medical recognized at Scrip Awards 2008
... for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. For further information please visit our website at http://biomsmedical.com ...Genmab A/S: Ofatumumab Pivotal CLL Data to be Presented at ASH
... is being developed to treat chronic lymphocytic leukemia, follicular non-Hodgkin's lymphoma, diffuse large B-cell lymphoma, rheumatoid arthritis and relapsing remitting multiple sclerosis under a co-development and commercialization agreement between Genmab and GlaxoSmithKline. It is not yet approved for ...Peptimmune Presentations at Upcoming Events
... establishment of safety at potentially therapeutic doses and proof of pharmacologic mechanism, the Company plans to initiate its Phase II study in relapsing remitting multiple sclerosis patients in early 2009. PI-2301 is a second-generation peptide copolymer from a similar compound class as Copaxone(R) ...